{"name":"Sigma-Tau Research, Inc.","slug":"sigma-tau-research-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PLC","genericName":"PLC","slug":"plc","indication":"Advanced solid tumors","status":"phase_3"}]}],"pipeline":[{"name":"PLC","genericName":"PLC","slug":"plc","phase":"phase_3","mechanism":"PLC is a drug that targets the PI3K/AKT pathway.","indications":["Advanced solid tumors"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQYnJES0x1Nnl6ZGVlbzJET29fU092Q05VTGhjWDRXWXROLXFqYTg2Wjc4WVRDLUFOTGRsdW9ncEE4N0paaFQtb2VuYjhWMmlIaFRhVjJsUzNkWkpxemJJZm41eDhGT0xQRHEzVnFaWHpQOXp4b1NyTlVJbEg1MklibUs4VjFiRUZIRV8zaEFrN1Y?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Outlook for the Adenosine Deaminase-Severe Combined - openPR.com","headline":"Outlook for the Adenosine Deaminase-Severe Combined","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNUTlBMXJCN0MzODBoT2JGaWdKaVZHSEh0NEY5RS0tXzY1MmlBeGszc2k1UkFDV25LRTlQNW56aVFMeWdMcGNkMGlIYTZXQlFGWURvYjhaRUYtUktSbkNJUy1BSGI5SjZVMkZHeEJmOFRqOThxazJFaUtMUldGWUM4TVdleDV3QnBjTWk3SGI5OU5qaWVRVUE?oc=5","date":"2026-02-12","type":"pipeline","source":"PharmTech.com","summary":"European Biotechs Impacting Treatment of Alzheimer’s Disease - PharmTech.com","headline":"European Biotechs Impacting Treatment of Alzheimer’s Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxQeGpVb3ZCYnZ4Mm5fZnRQTkM2aDNDOHRBY19VZTJPek51Z0Fkcy1uSlNxOVR5SzVSWkdrOU9sSnh4SjJtYWlmdWNkN0JMalIxS2ZiRTdVeFBBX2lfeUhkRzBFSVJZVnB6d0RRSHkyQ19ULWs4RThsLWhEczZ5NnpiRTRqa0JPcXptRnVhRDMxQkdHclZsMUZKNUpHblFaTk1SOU5OakhmejRLN0VxTUNzakN6dUkwUk4wNGVkcFBPa2JkbDZ4c0tFV0xVeVNqalA2YmdRMlREdmc5ck5raE1qVnVIRGpyNTU0UVRLQ3JaWnhhVkg1ODBkRThlVllTNkJ0V3JhOWlsTUNaN24xeXZVX09jMGZkXzJkS3JRRjltdnNQVkRDV1UxbXd5TnM?oc=5","date":"2025-08-05","type":"pipeline","source":"GlobeNewswire","summary":"Lipid Nanoparticles Market Industry Trends, Key Growth - GlobeNewswire","headline":"Lipid Nanoparticles Market Industry Trends, Key Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPRlpFYllzNHk1VUh3TVJLX2pmRFlwSjNrQ3pTeERxb3c2c2RUaFduVEJFOGJnenJMSWZUdnI2X0c3c3hCNGQza3lQQTNwVkYzSzJmNHVfWTRHR0ItTWo0SmMyc253YUNOSDRWT3ZPb0lUX1dRS0dfWlpzTkgybGlQNkVqODhnRWZwMEp2d3JxUTl2OG5EYUUyUXJ4OA?oc=5","date":"2024-08-05","type":"pipeline","source":"citybiz","summary":"Fennec Pharmaceuticals Appoints Jeffrey S. Hackman As CEO - citybiz","headline":"Fennec Pharmaceuticals Appoints Jeffrey S. Hackman As CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AJBVV95cUxOcWdtWlF4SU1sUzlOOXlKU2g1Yjh6YlYzS0ZYSlFuZHhubDhYd19Cc0V2NUFEcXlSeURLbkVzSHBSaWFEWFRKVnJKbFpkby1pa3VGR3k3UHlnOF9Gd1NlTk55WmlsQ0FMLTU4ZWNkUmF0azVRVGJYTnlaQ2g4bFFVeVI3djFZWXBNZ1BMT0MwTlVfdUZMeEZ6SW1pak1udWFHUldYLU9pemh2b0YxSGttRnBoZnd6SU9TOVl1cjAwcHRSaDRxSEQzaVBmVnFNdDFQMzhFRVNrOU9ONEdLTHB6ZDE3aGtqNTNRdF8tYXJYNWQ4cnRCVTR2cUtfa0IxVDZWa3FRa0h0UFUxMVJ5bFF0aVYybjNzb29nTWJISVEyU1g3aVhzSjRQNlV1cjJkV2FKRmd3TVVmR24wWjRrWUxOLXh6X1NqUmVMUUNIZFFxdEJTZ1ZoZmN6TFRVaWN3U0huc2tNdQ?oc=5","date":"2024-03-13","type":"deal","source":"businesswire.com","summary":"Pharmaceutical and Biotechnology Royalty Rates Report and Directory 2024: Technology Licensed, License Fees, Upfront and Milestone Payments for Deals Signed Since 2020 - ResearchAndMarkets.com - busin","headline":"Pharmaceutical and Biotechnology Royalty Rates Report and Directory 2024: Technology Licensed, License Fees, Upfront and","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNejlNdWgySEt2ZkR6UHJQeEV3UzF3cnduTzJqaFktNmVlTXlXZ1NCTGFaY3B1RzMyNl9td1Q3dWlPa2NfOG1jbFVyT3hWSlduRFM2VzZrSW40ZnhkOFBBTE4zeV9LNG1feEhjUEIycXdnUGpfLVJKZ2ZmZmFpeFFTVU1nQTkwa3NVS2I0cXhGOGg1UQ?oc=5","date":"2022-01-06","type":"deal","source":"pharmaphorum","summary":"Another mRNA company gets snapped up as Merck buys Exelead - pharmaphorum","headline":"Another mRNA company gets snapped up as Merck buys Exelead","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWEpBQS1yWGNyMGNZVWJnSHh4MTNMaWE2UlhZd0plLWxQRl9aLWVlc3J0bXM3aXVRa25kM3lNd3VqZm9IUkNBbFN3dVBzazJZbGQweEl3aUFOVnR0MGRROGNZSW5SMEtneVM2Tkp3dmdJYl9Ua2hJU1QzR2NHSDF5X0ZhLUMwMGlmaUJBZHZINmF1MTZWTE8wa0NNUDQ0T2ptNXExZkNsNUVrNW8?oc=5","date":"2017-03-10","type":"pipeline","source":"The Business Journals","summary":"Why a Gaithersburg drug company just gave itself a new name - The Business Journals","headline":"Why a Gaithersburg drug company just gave itself a new name","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE1zNlZDWjBETk5hLUZsd0lsbTlLSTNDdG5MT1YxTjlwQks5b3ZvdTFqUURGRFV3UHNKY2JoQ1U4ck10Q1JWYmtNbVQwQk1IVm1rc2drU3QtbTNxbmQ4M2lEMFVKTTN0dU9selNyM0c5cHBqeFRi0gF0QVVfeXFMTWNZd3FMSXBPZTVqem9hUkw4alEwWnlfRVpvWm5Qam9IVTFlUDBLck5Bblp2dzAxbjFlUzJlN1Z5X0I5LXdFUDdicXhvemJybndTUGl1LTRTUmtteEZOZzVkY0JFaXJtcDJiUkp0T3VQckhlWmQ?oc=5","date":"2017-01-19","type":"pipeline","source":"Miami Herald","summary":"The Orphan Drug Act helps pay for rare illness meds. But pharma companies abuse it - Miami Herald","headline":"The Orphan Drug Act helps pay for rare illness meds. But pharma companies abuse it","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQUkJiUVhtLWc5RVFBVzVqQnRRRnE3SzFhMElTTnFfXzVlZVFKVlMxMXg3WDhZaERWdmFuMTNkcG9JSjRRaEVPVWttdVVoOW9XRHZQUFdiRGFSb2cxdThCMFo3UXU4ZDVHMi04aFJ3OGswSmJsUFlkeFRsa2JmenE0TE1rbTlNZkpIV3BHNk1tTmVpZGV6STVCM3RiZ25GdzhsXzNCN25vSEwtMWh3bjlyYmQzdHlxcjdVWmJCNWduWVJXWFZjTHJneU5tMjVqZkNocXlsS011am5ralRENEFr?oc=5","date":"2016-05-24","type":"pipeline","source":"prnewswire.com","summary":"15 Years And Going Strong, VSL#3® Maintains Leadership In The Probiotic Medical Food Category - prnewswire.com","headline":"15 Years And Going Strong, VSL#3® Maintains Leadership In The Probiotic Medical Food Category","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNT0Q2OTJFUjN4b3dSdGpQRjVaWVpSRkVORV9CLVY4UVJ5TmpDLVdpNHZjVG1McS14RjRqNFc4WEVWcjhPMXVZUG1KRWVuOVh6Y1VpV20wR0VsdG82Tmw0a3dlZXBmX2xOQkRBYzhIeTlwREVJa2tQOXdWTGxTN2RiQlAwWk1wN1BqUlA1NkdteUhWX3lua0hyWFJVWEVEZw?oc=5","date":"2015-05-15","type":"pipeline","source":"Allied Market Research","summary":"Acute Lymphocytic Leukemia Therapeutics Market Share 2030 - Allied Market Research","headline":"Acute Lymphocytic Leukemia Therapeutics Market Share 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPeW1rM3Zfb2JmQ1VFZEFrWE5FMTBUdWFJRkpiRDBISlExTUlOc2s5WWtmSWFxa19uWXRrbWdoYjQzY2ZwenlZNklGQnZBenFOLTNWVUVDc3pXdnVOZmg2Q2F2emVWZlAzZjZKSGV6MHFBYmdPQkhWUDI5MXpTVG96V0plM2dFSFhVR2RzdkZTUGJQd210aHFpNE5BMlg4ekpDNklXRWJMWVBwa1BPc0hhaExXT082dC1PMmtVQVd4VzQ?oc=5","date":"2012-10-05","type":"regulatory","source":"National Human Genome Research Institute (NHGRI) (.gov)","summary":"FDA approves crystal-dissolving eye drops, a major milestone for NIH rare disease researchers - National Human Genome Research Institute (NHGRI) (.gov)","headline":"FDA approves crystal-dissolving eye drops, a major milestone for NIH rare disease researchers - National Human Genome Re","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFA1SHVaQ3RpODBTcXJsNGVlVmJzZnVfS0gyZUtFQXhnN1dJV0IyNkp4VW9XZVF0YVVLSTZocHBwRGJKOXNxaXpBbU1Ub3NXNzcwakhLVHRVY2pBdGF2aEdndWluRldzaHVSdVdraklma2ZIQmlZYUE?oc=5","date":"2008-12-15","type":"pipeline","source":"C&EN","summary":"Two Advances On The Malaria Front - C&EN","headline":"Two Advances On The Malaria Front - C&EN","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}